Avanafil in treatment of post-surgical ED for men with localized prostate cancer

Data published on line in the Journal of Urology last December suggest that the new PDE5 inhibitor known as avanafil or Stendra® is supposedly effective in combating erectile dysfunction (ED) in just over one-third of men with ED at 6 months after bilateral, nerve-sparing radical prostatectomy. … READ MORE …

Data from large, retrospective study shows 5-year efficacy for SBRT in localized prostate cancer

Data from a large, retrospective, multi-center study of stereotactic body radiation therapy (SBRT) with CyberKnife technology in the treatment of men with localized prostate cancer were presented on Wednesday afternoon at the annual meeting of the American Society for Radiation Oncology (ASTRO). … READ MORE …

Relative cost-effectiveness of SBRT and IMRT in treatment of localized prostate cancer

A new paper in the Journal of Oncology Practice has attempted to compare the cost-effectiveness of stereotactic body radiation therapy (SBRT) to that of intensity-modulated radiation therapy (IMRT) in the treatment of men with low- to intermediate-risk prostate cancer. … READ MORE …

Is salvage cryotherapy really as safe and effective as some suggest?

There have been an increasing number of articles published in the recent past suggesting salvage cryotherapy as an excellent option for the treatment of men with progressive prostate cancer after failure of first-line radiation therapy. … READ MORE …

Side effect profile of MDV3100 appears highly promising in mCRPC

According to a number of media reports today, Medivation’s investigational drug MDV3100 appears to have a relatively good safety profile, although five patients who received MDV3100 in the completed Phase III trial did have seizures. … READ MORE …

ASTRO claims “Proton therapy effective prostate cancer treatment”

A media release issued yesterday by ASTRO reads as follows: … READ MORE …